Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway

Fig. 5

DT inhibits the protein expression of DNA damage response proteins in prostate cancer cells. Total cell extracts of DU145 cells (a) or PC-3 cell (b) were harvested from untreated cells and cells treated with DMSO or DT for 0, 6 h. The protein was immunoblotted with polyclonal antibodies specific for DNA damage response proteins (γ-H2AX and phosphorylated-ATM). α-tubulin was used as an internal loading control

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us